Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia

Leukemia

Volumn 25, Issue 6, 2011, Pages 953-959

  Escherich, G ^a   Richards, S ^b   Stork, L C ^c   Vora, A J ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

childhood; mercaptopurine; systematic review; thioguanine; thiopurine

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; DRUG CHOICE; DRUG MEGADOSE; EVENT FREE SURVIVAL; GROUPS BY AGE; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; THROMBOCYTOPENIA;

6-MERCAPTOPURINE; AGE FACTORS; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; FEMALE; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; SURVIVAL ANALYSIS; THIOGUANINE; TREATMENT OUTCOME;

EID: 79958158124     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.37     Document Type: Article

References (8)

1. Harms DO, Gobel U, Spaar HJ, Graubner UB, Jorch N, Gutjahr P et al. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood 2003; 102: 2736-2740. (Pubitemid 37248841)
2. Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J et al. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 2006; 368: 1339-1348. (Pubitemid 44528747)
3. Stork LC, Sather H, Hutchinson HJ, Broxson EH, Matloub Y, Yanofsky R et al. Comparison of mercaptopurine (MP) with thioguanine (TG) and IT methotrexate (ITM) with IT 'Triples' (ITT) in children with SR-ALL: results of CCG-1952. Blood 2002; 100: 156a, A585.
4. Stork LC, Matloub Y, Broxson E, La M, Yanofsky R, Sather H et al. Oral 6-mercaptopurine versus oral 6-thioguanine and venoocclusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. Blood 2010; 115: 2740-2748.
5. Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG). Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis. Br J Haematol 2009; 145: 376-388.
6. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. (Pubitemid 37088507)
7. Lennard L, Lilleyman JS. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol 1989; 7: 1816-1823. (Pubitemid 20014328)
8. Lilleyman JS, Lennard L, Rees CA, Morgan G, Maddocks JL. Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization. Br J Cancer 1984; 49: 703-707. (Pubitemid 14113726)